Evidence map›Paper›PMID 30444203›Full record

ArticleAnti-inflammatory & anti-allergy agents in medicinal chemistry2019

In vivo, Extract from Withania somnifera Root Ameliorates Arthritis via Regulation of Key Immune Mediators of Inflammation in Experimental Model of Arthritis.

Mahmood Ahmad Khan, Rafat Sultana Ahmed, Nilesh Chandra, Vinod Kumar Arora, Athar Ali

Abstract read
In one paragraph

Article in Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Effects of Ashwagandha (Nutrients · 2020
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Extraction of Bioactive Compounds FromInternational journal of food science · 2025
    Review
  7. Article
  8. Review
  9. Anti-inflammatory and anti-angiogenic effects ofJournal of medicine and life · 2024
    Article
  10. Emerging Vistas for the NutraceuticalPharmaceuticals (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Review
  13. Phytochemicals ofMicroorganisms · 2023
    Review
  14. The immunomodulatory role ofFrontiers in pharmacology · 2023
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Frontiers in cellular and infection microbiology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahmood Ahmad KhanDepartment of Biochemistry, University College of Medical Sciences and GTB Hospital, Dilshad Garden, Delhi, India.
Rafat Sultana AhmedDepartment of Biochemistry, University College of Medical Sciences and GTB Hospital, Dilshad Garden, Delhi, India.
Nilesh ChandraDepartment of Biochemistry, Subharti Medical College, Meerut, Uttar Pradesh, India.
Vinod Kumar AroraDepartment of Pathology, University College of Medical Sciences and GTB Hospital, Dilshad Garden, Delhi, India.
Athar AliDepartment of Biotechnology, Jamia Hamdard, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRheumatoid Arthritis (RA) is a devastating disease characterized by continual addition of leukocytes and T cells within the articular cavity causing inflammation and cartilage destruction. Withania somnifera is one of the most precious medicinal herbs, reported to have antioxidant, anti-inflammatory, and immunomodulatory properties.

objectiveThe purpose of this study was to evaluate anti-inflammatory activity of aqueous extract of Withania somnifera roots (WSAq) in Collagen Induced Arthritic (CIA) rats.

methodsTo achieve this, we assessed the level of inflammatory cytokines such as Tumor Necrosis Factor (TNF)-α, IL-1β, IL-6 and IL-10 in CIA rats. Further, transcription factor, oxidative stress parameters and CD+8 expressions were also analyzed in CIA rats.

resultsArthritic rats showed a greater increase in the levels of pro inflammatory cytokines such as TNF-α, IL-1β, IL-6, transcription factor NF-κB and a decrease in IL-10 concentration than controls rats. Oral administration of WSAq at a dose of 300mg/kg.wt. (WSAq300) appreciably attenuated the production of these pro inflammatory cytokines. This anti-inflammatory activity of WSAq300 might be partly mediated through an increase in the secretion of IL-10 and inhibition of NF-κB activity. Further, arthritic rats also show increased oxidative stress as compared to control rats. This increased oxidative stress in the arthritic rats appears to be the outcome of both an activated pro-oxidant and a poor antioxidant defense system. Treatment with WSAq300 strongly ameliorates all these ROS parameters significantly to near normal. Additional, metalloproteinase MMP-8 levels were also measured and found to be increased in CIA rats, which after treatment with WSAq300 came down to near normal.

conclusionFrom the above results, it can be concluded that the use of WSAq300 may be a valuable supplement which can improve human arthritis.

Indexed as

WithaniaAnimalsArthritis, ExperimentalCytokinesDisease Models, AnimalInflammation MediatorsMaleOxidative StressPhytotherapyPlant ExtractsPlant RootsRandom AllocationRats, WistarCytokinesInflammation MediatorsPlant ExtractsCollagen induced arthritisinflammationjoint destructionoxidative stressrheumatoid arthritis.Withania somnifera

Identifiers

PMID30444203
PMCPMC6446523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.